AstraZeneca spins out new firm Viela Bio
admin 28th February 2018 Uncategorised 0AstraZeneca’s biologics research and development arm MedImmune has spun out six molecules from its early-stage inflammation and autoimmunity programmes into new independent biotech Viela Bio.
More: AstraZeneca spins out new firm Viela Bio
Source: News